The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia
- PMID: 37633274
- PMCID: PMC10518590
- DOI: 10.1016/j.xcrm.2023.101167
The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia
Abstract
Bacterial pneumonia is a considerable problem worldwide. Here, we follow the inter-kingdom respiratory tract microbiome (RTM) of a unique cohort of 38 hospitalized patients (n = 97 samples) with pneumonia caused by Legionella pneumophila. The RTM composition is characterized by diversity drops early in hospitalization and ecological species replacement. RTMs with the highest bacterial and fungal loads show low diversity and pathogen enrichment, suggesting high biomass as a biomarker for secondary and/or co-infections. The RTM structure is defined by a "commensal" cluster associated with a healthy RTM and a "pathogen" enriched one, suggesting that the cluster equilibrium drives the microbiome to recovery or dysbiosis. Legionella biomass correlates with disease severity and co-morbidities, while clinical interventions influence the RTM dynamics. Fungi, archaea, and protozoa seem to contribute to progress of pneumonia. Thus, the interplay of the RTM equilibrium, the pathogen load dynamics, and clinical interventions play a critical role in patient recovery.
Keywords: Legionella pneumophila; biomass; microbial ecology; pneumonia; respiratory tract microbiome; severity.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures







Similar articles
-
Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms.mBio. 2020 May 19;11(3):e00889-20. doi: 10.1128/mBio.00889-20. mBio. 2020. PMID: 32430469 Free PMC article.
-
Altered Ecology of the Respiratory Tract Microbiome and Nosocomial Pneumonia.Front Microbiol. 2022 Feb 10;12:709421. doi: 10.3389/fmicb.2021.709421. eCollection 2021. Front Microbiol. 2022. PMID: 35222291 Free PMC article.
-
Ecology of the respiratory tract microbiome.Trends Microbiol. 2023 Sep;31(9):972-984. doi: 10.1016/j.tim.2023.04.006. Epub 2023 May 10. Trends Microbiol. 2023. PMID: 37173205 Review.
-
The Respiratory Tract Microbiome and Human Health.Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147. Microb Biotechnol. 2025. PMID: 40293161 Free PMC article. Review.
-
Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia.Front Immunol. 2018 Nov 16;9:2640. doi: 10.3389/fimmu.2018.02640. eCollection 2018. Front Immunol. 2018. PMID: 30505304 Free PMC article. Review.
Cited by
-
Deep longitudinal lower respiratory tract microbiome profiling reveals genome-resolved functional and evolutionary dynamics in critical illness.Nat Commun. 2024 Sep 27;15(1):8361. doi: 10.1038/s41467-024-52713-8. Nat Commun. 2024. PMID: 39333527 Free PMC article.
-
Severe Legionnaires' disease.Ann Intensive Care. 2024 Apr 2;14(1):51. doi: 10.1186/s13613-024-01252-y. Ann Intensive Care. 2024. PMID: 38565811 Free PMC article. Review.
-
Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation.Pneumonia (Nathan). 2025 May 5;17(1):10. doi: 10.1186/s41479-025-00163-1. Pneumonia (Nathan). 2025. PMID: 40320531 Free PMC article.
-
Enrichment of Streptococcus oralis in respiratory microbiome enhance innate immunity and protects against influenza infection.Signal Transduct Target Ther. 2025 Aug 27;10(1):272. doi: 10.1038/s41392-025-02365-x. Signal Transduct Target Ther. 2025. PMID: 40858544 Free PMC article.
-
Optimization of lung tissue pre-treatment by bead homogenization for subsequent culturomics.Sci Rep. 2024 Sep 30;14(1):22724. doi: 10.1038/s41598-024-69736-2. Sci Rep. 2024. PMID: 39349927 Free PMC article.
References
-
- Faner R., Sibila O., Agustí A., Bernasconi E., Chalmers J.D., Huffnagle G.B., Manichanh C., Molyneaux P.L., Paredes R., Brocal V.P., et al. The microbiome in respiratory medicine: Current challenges and future perspectives. Eur. Respir. J. 2017;49:1–12. doi: 10.1183/13993003.02086-2016. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources